Myeloproliferative disorder therapy: assessment and management of adverse events-a psychiatrist's perspective.
- Published in:
- Hematological Oncology, 2009, v. 27, n. S1, p. 14, doi. 10.1002/hon.913
- By:
- Publication type:
- Article
Works matching IS 02780232 AND DT 2009 AND VI 27 AND IP S1
Results: 6
1
2
Myeloproliferative disorder therapy: assessment and management of adverse events-a dermatologist's perspective.
- Published in:
- Hematological Oncology, 2009, v. 27, n. S1, p. 11, doi. 10.1002/hon.912
- By:
- Publication type:
- Article
3
Defining targets in myeloproliferative disorders: reflecting on what is important.
- Published in:
- Hematological Oncology, 2009, v. 27, n. S1, p. 2, doi. 10.1002/hon.909
- By:
- Publication type:
- Article
4
Myeloproliferative disorder therapy: assessment and management of adverse events-a cardiologist's perspective.
- Published in:
- Hematological Oncology, 2009, v. 27, n. S1, p. 8, doi. 10.1002/hon.911
- By:
- Publication type:
- Article
5
Introduction.
- Published in:
- Hematological Oncology, 2009, v. 27, n. S1, p. 1, doi. 10.1002/hon.908
- By:
- Publication type:
- Article
6
New perspectives in managing myeloproliferative disorders: focus on the patient.
- Published in:
- Hematological Oncology, 2009, v. 27, n. S1, p. 5, doi. 10.1002/hon.910
- By:
- Publication type:
- Article